University of Alabama, Birmingham — Birminham, Alabama

University of Alabama, Birmingham is a clinical research site located in Birminham, Alabama, United States.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Alabama, Birmingham has participated in 2 clinical trials.

Therapeutic areas: Paroxysmal Atrial Fibrillation, Head and Neck Squamous Cell Carcinoma (HNSCC).

Sponsors: CardioFocus, Navidea Biopharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama, Birmingham?

University of Alabama, Birmingham has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama, Birmingham conducted?

University of Alabama, Birmingham has 2 clinical trials on record. Their work covers Paroxysmal Atrial Fibrillation, Head and Neck Squamous Cell Carcinoma (HNSCC).

Is University of Alabama, Birmingham accredited by Crixeo Health?

University of Alabama, Birmingham has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama, Birmingham?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.